| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/12/2001 | CA2396529A1 O-superfamily conotoxin peptides |
| 07/12/2001 | CA2396422A1 Preparation of deallergenized proteins and permuteins |
| 07/12/2001 | CA2396401A1 Novel fgf homolog zfgf12 |
| 07/12/2001 | CA2396399A1 Methods for protein transfer |
| 07/12/2001 | CA2396364A1 Epididymal antimicrobial peptides |
| 07/12/2001 | CA2396355A1 Nope polypeptides, encoding nucleic acids and methods of use |
| 07/12/2001 | CA2396173A1 Chemically modified hiv envelope glycoprotein |
| 07/12/2001 | CA2396149A1 Transduction of recombinases for inducible gene targeting |
| 07/12/2001 | CA2396114A1 Methods of modulation of the immune system |
| 07/12/2001 | CA2396040A1 Novel bacterial genes and proteins that are essential for cell viability and their uses |
| 07/12/2001 | CA2396036A1 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| 07/12/2001 | CA2395945A1 Novel chimeric proteins and methods for using the same |
| 07/12/2001 | CA2395876A1 Nucleic acids encoding (poly)peptides having chips activity |
| 07/12/2001 | CA2395625A1 Progenitor cell preservation factors and related methods and products |
| 07/12/2001 | CA2395198A1 Pp14 fusion proteins and methods for making and using the same |
| 07/12/2001 | CA2395041A1 Stabilizing peptides, polypeptides and antibodies which include them |
| 07/12/2001 | CA2394730A1 Novex polypeptides, nucleic acids encoding same and their diagnostic and therapeutic use |
| 07/12/2001 | CA2394597A1 Enhancing the immune response to an antigen by presensitizing with an inducing agent prior to immunizing with the inducing agent and the antigen |
| 07/12/2001 | CA2392844A1 Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast |
| 07/12/2001 | CA2388566A1 Mutm orthologue and uses thereof |
| 07/12/2001 | CA2329318A1 Transgenic animal model of basal cell carcinoma |
| 07/11/2001 | EP1114867A1 Transcription regulatory sequences derived from Chlamydomonas reinhardtii |
| 07/11/2001 | EP1114865A1 Production of human parathyroid hormone |
| 07/11/2001 | EP1114864A2 Mammalian cell surface antigens, related reagents |
| 07/11/2001 | EP1114863A2 Heregulins (HRGs), binding proteins of P185erb2 |
| 07/11/2001 | EP1114862A2 Use of polyeptides or their encoding nucleic acids for the diagnosis or treatment of skin diseases and their use in indentifying pharmacologically acitve substances |
| 07/11/2001 | EP1114861A1 Ly6h gene |
| 07/11/2001 | EP1114860A1 Method for the diagnosis of cell proliferative disease |
| 07/11/2001 | EP1114830A1 Cerebral organic anion transporter and its gene |
| 07/11/2001 | EP1114829A2 Alloferons - Immunomodulatory peptides |
| 07/11/2001 | EP1114189A1 Recombinant newcastle disease virus rna expression systems and vaccines |
| 07/11/2001 | EP1114171A1 Methods for treatment of degenerative retinal diseases |
| 07/11/2001 | EP1114170A2 Maize replication protein a |
| 07/11/2001 | EP1114166A1 Method for down-regulating osteoprotegerin ligand activity |
| 07/11/2001 | EP1114160A1 Moraxella catarrhalis basb034 polypeptides and uses thereof |
| 07/11/2001 | EP1114159A1 Methods and compositions relating to egf-repeat-containing polypeptides |
| 07/11/2001 | EP1114158A2 Human cytoskeleton associated proteins |
| 07/11/2001 | EP1114157A2 Regulatory protein from human keratinocytes |
| 07/11/2001 | EP1114156A2 Mammalian transforming growth factor beta - 9 (ztgfss9) |
| 07/11/2001 | EP1114155A2 Human gpcr proteins |
| 07/11/2001 | EP1114154A2 Compositions and methods for the treatment of immune related diseases |
| 07/11/2001 | EP1114153A2 Lynx, a novel family of receptor ligands in the central nervous system, corresponding nucleic acids and proteins and uses therof |
| 07/11/2001 | EP1114152A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/11/2001 | EP1114151A1 G protein-coupled receptor agonists or antagonists |
| 07/11/2001 | EP1114149A1 Rnase p polypeptides |
| 07/11/2001 | EP1114145A1 Topa |
| 07/11/2001 | EP1114143A1 Streptococcal c beta protein compositions |
| 07/11/2001 | EP1114063A2 A method of producing a functional immunoglobulin superfamily protein |
| 07/11/2001 | EP1114062A1 MODIFIED $i(E. COLI) ENTEROTOXIN II SIGNAL PEPTIDE AND A MICROORGANISM EXPRESSING A FUSION PROTEIN OF SAID PEPTIDE AND A HETEROLOGOUS PROTEIN |
| 07/11/2001 | EP1114060A1 Process for producing peptides from biological fluids and peptides obtainable by said process |
| 07/11/2001 | EP1114059A1 Regulation of immune responses by attractin |
| 07/11/2001 | EP1114058A1 Polynucleotide and polypeptide sequences encoding rat mdr1a and screening methods thereof |
| 07/11/2001 | EP1113839A2 Variable output applicator and method for multi-component biologic fluid agents |
| 07/11/2001 | EP1113814A1 Human chorionic gonadotropin vaccines |
| 07/11/2001 | EP1113811A1 Chemokine receptor antagonist and cyclosporin in combined therapy |
| 07/11/2001 | EP1113810A2 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
| 07/11/2001 | EP1113808A1 A method of treatment and agents useful for same |
| 07/11/2001 | EP1113777A2 Novel hepatitis c virus peptides and uses thereof |
| 07/11/2001 | EP1019433A4 Protein composition and process for isolating a protein composition from a muscle source |
| 07/11/2001 | EP0969865A4 Mhc class ii antigen-presenting systems and methods for activating cd4?+ t cells |
| 07/11/2001 | EP0820489B1 Hybrid phthalocyanine derivatives and their uses |
| 07/11/2001 | EP0600018B1 Hepatitis c assay utilizing recombinant antigens to c-100 region |
| 07/11/2001 | EP0593516B1 Methods of treatment of motor neuron diseases using members of the bdnf/nt-3/ngf family of molecules |
| 07/11/2001 | EP0495064B1 Birch pollen allergen p14 for diagnosis and therapy of allergic diseases |
| 07/11/2001 | CN1303442A Method |
| 07/11/2001 | CN1303441A Cotton cells, plants and seeds genetically engineered to express insecticidal and fungicidal chitin binding proteins (lectins) |
| 07/11/2001 | CN1303439A Novel constructs for controlled expression of recombinant proteins in prokaryotic cells |
| 07/11/2001 | CN1303438A Method of cancer diagnosis using chimeric toxin |
| 07/11/2001 | CN1303433A Recombinant potyvirus construct and use thereof |
| 07/11/2001 | CN1303432A Novel insecticidal toxins from i(xenorhabdus nematophilus) and nucleic acid sequences coding therefor |
| 07/11/2001 | CN1303429A Therapeutic applications of mature FLINT (mFLINT) polypeptides or OPG3, member of TNF receptor superfamily |
| 07/11/2001 | CN1303425A PNS cell lines and methods of use therefor |
| 07/11/2001 | CN1303394A Peptide compound for preventing and treating HIV infection and immunity diseases |
| 07/11/2001 | CN1303392A Method for separating and/or isolating plasma proteins by annularchromatography |
| 07/11/2001 | CN1303301A Use of anti-gp 39 antibodies for treatment and/or reversal of lupus and associated kidney disease |
| 07/11/2001 | CN1303300A Isolated peptides corresponding to amino acid sequences of NY-ESO-1, wherein bind to MHC class I and MHC class II molecules, and uses thereof |
| 07/11/2001 | CN1303299A Method and compositions for peptide synthesis |
| 07/11/2001 | CN1303298A Gene therapy approaches to supply apolipoprotein A-1 agonists and their use to treat dyslipidemic disorders |
| 07/11/2001 | CN1302890A Human protein translation initiation factor and its coding sequence |
| 07/11/2001 | CN1302889A Polypeptide-human protein 70 containing plasmolemma regulation function and polynucleotide for coding it |
| 07/11/2001 | CN1302888A Polypeptide-human rigor factor 23 and polynucleotide for coding it |
| 07/11/2001 | CN1302887A Polypeptide-dyein light-medium chain 58 and polynucleotide for coding it |
| 07/11/2001 | CN1302886A Polypeptide-human cell wither correlated protein 12 and polynucleotide for coding it |
| 07/11/2001 | CN1302885A Polypeptide-human autoimmune disease correlated protein 16 and polynucleotide for coding it |
| 07/11/2001 | CN1302884A Polypeptide-human eukaryote initiation factor 50 and polynucleotide for coding it |
| 07/11/2001 | CN1302883A Polypeptide-human enameling protein 23 and polynucleotide for coding it |
| 07/11/2001 | CN1302882A Polypeptide-human ankyrin 27 and polynucleotide for coding it |
| 07/11/2001 | CN1302881A Polypeptide-human beta-galactoside binding protein and polynucleotide for coding it |
| 07/11/2001 | CN1302880A Polypeptide-human shearing factor 25 and polynucleotide for coding it |
| 07/11/2001 | CN1302879A Polypeptide-human F-actin binding factor 75 and polynucleotide for coding it |
| 07/11/2001 | CN1302878A Polypeptide-G protein 17 and polynucleotide for coding it |
| 07/11/2001 | CN1302877A Polypeptide-human nuclein II precursor protein 25 and polynucleotide for coding it |
| 07/11/2001 | CN1302876A Human charcot-leyden crystal 4, its coding sequence, its preparing process and its application |
| 07/11/2001 | CN1302875A Human Charcot-leyden crystal 5, its coding sequence, its preparing process and its application |
| 07/11/2001 | CN1302874A Polypeptide-translation initiation factor helper factor 28 and polynucleotide for coding it |
| 07/11/2001 | CN1302873A Nucleotide sequence of output protein of encode side chain amino acid and separation method and application thereof |
| 07/11/2001 | CN1302818A Human chorionic gonadotropin and its preparing process |
| 07/11/2001 | CN1302817A Polypeptide-human S4 ribosomal protein 20 and polynucleotide for coding it |
| 07/11/2001 | CN1302816A Polypeptide-human DnaJ protein 42 and polynucleotide for coding it |
| 07/11/2001 | CN1302815A Polypeptide-human COP9 compound subunit 30 and polynucleotide for coding it |